InvestorsHub Logo
Boards
News
Market Data
Markets
Discover
Discover
Subscribe Login/Register
S&P 500
5,222.68
(
0.16%
)
US TECH 100
17,650.00
(
0.05%
)
Dow Jones
39,512.84
(
0.32%
)
Brent Oil
82.59
(
0.00%
)
Bitcoin
61,142.36
(
0.57%
)
Post# of 216685
Next 10
Reply Private New
Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next

BottomBounce

Send PM Follow Ignore
Followers 898
Posts 148975
Boards Moderated 0
Alias Born 08/13/2010

BottomBounce

Re: Penny Roger$ post# 97510

Tuesday, 09/23/2014 8:20:09 AM

Tuesday, September 23, 2014 8:20:09 AM

Post# of 216685
VIVUS, Inc. NASDAQ: $VVUS [Trend Analysis] along with Auxilium Pharmaceuticals, Inc. (AUXL) recently declared that the FDA has permitted their erectile dysfunction (ED) drug, Stendra’s supplemental new drug application (sNDA) to include 15 minutes onset of action. VIVUS has teamed up for the drug with privately -held Italian pharmaceutical firm, Menarini (over 40 European countries, Australia and New Zealand), Sanofi (Africa, the Middle East, Turkey, and the Commonwealth of Independent States including Russia) and Auxilium Shares of VIVUS, Inc. (NASDAQ:VVUS)

I am NOT a Financial Adviser. Nothing I say, post, or do should be considered financial advice. I may be holding a long, short or no position. I am NOT compensated to post on here and all my posts are for entertainment purposes only.

Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Last Read Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.

Sign Up